1.
Lee MW SC. Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor. Acta Derm Venereol [Internet]. 2004 Mar. 26 [cited 2026 Jun. 1];84(1):23-6. Available from: https://medicaljournalssweden.se/actadv/article/view/11374